Definitive Contract 75D30118C02900

Award Date 9/10/18
Potential Completion Date 9/29/19
Potential Value $387K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60612, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price definitive contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Rush University Medical Center, a non-profit academic medical center and hospital located in Chicago, Illinois. The $518,542.00 contract is for "Genomic Epidemiology of MRSA" with a period of performance through April 29, 2020. The contract does not have a set-aside designation. Rush University Medical Center, operating under the...
Rush University Medical Center was awarded a $502,185 firm fixed price definitive contract by the Department of Health and Human Services Centers for Disease Control and Prevention to evaluate the emergence of resistance and changes in clinical pathogens following the introduction of chlorhexidine bathing. Under the contract, Rush will conduct the requested evaluation and is supported by subcontractors Regents of the University of Michigan and Harvard Pilgrim Health Care Inc. The originating...
Rush University Medical Center, doing business as Rush-Presbyterian St. Luke's Hospital, has been awarded a $500,000 firm fixed price delivery order against the Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) 2016 master indefinite-delivery/indefinite-quantity (IDIQ) contract by the Centers for Disease Control and Prevention (CDC). The delivery order is for work supporting Domain 1-A005 of the SHEPheRD 2021 program. As part of its mission to protect public health...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Rutgers, The State University of New Jersey, doing business as RBHS-New Jersey Medical School, a non-profit educational institution. The contract, with a firm fixed price of $150,000.00, is for rapid identification of Candida auris, a fungal pathogen of public health concern. The contract does not have a set-aside designation and was awarded on September 21, 2017,...
This federal contract was awarded by the National Institutes of Health (NIH) Clinical Center to Rush University Medical Center, a non-profit academic medical center based in Chicago, Illinois. The contract is for $23,835.50 to provide genetic sequencing services. It is a firm fixed-price purchase order with an ultimate completion date of August 25, 2025. The contract does not have a set-aside designation. Rush University Medical Center has a record of securing various federal contracts and...
This is a $589,237.33 grant awarded by the Shared Services Center, a civilian agency, to Rush University Medical Center, an academic medical center and hospital located in Chicago, Illinois. The grant, titled "REACH FOR INFORMATION TECHNOLOGY TRAINING," has a period of performance through July 31, 2023 and is not a set-aside contract. Rush University Medical Center frequently secures federal contracts and grants for providing a range of medical and research services to government...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $1,999,861 firm fixed price delivery order against the Safe Healthcare, Epidemiology, and Prevention Research Development Program indefinite-delivery/indefinite-quantity multiple award contract to Rush University Medical Center doing business as Rush-Presbyterian St. Luke's Hospital. The delivery order, numbered WW CENTRAL REGION 2022 DOMAINS 1-A004, is for epidemiology and prevention...
This is a $19,543,164.01 definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Rush University Medical Center. The contract is for a study titled "Innovative Support for Patients with SARS-CoV-2 Infections (INSPIRE) Registry" to determine the outcomes of SARS-CoV-2 infections among different age groups in the U.S. population. The contract was originally awarded on September 1, 2020 for an 18-month study with 4,800 participants. The CDC...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order to Prompt Diagnostics LLC, a for-profit limited liability company, to provide a rapid detection device for Candida auris. The potential value of the contract is $243,179, and the period of performance ends on September 25, 2023. Prompt Diagnostics is a provider of diagnostic devices and platforms for infectious diseases. This contract award supports the CDC's...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Definitive Contract to the University of Chicago, a private university and non-profit organization, to provide "NEW METAGENOMIC TOOLS FOR AR" services. The $227,820.00 Firm Fixed Price contract has a completion date of September 29, 2019. The contract does not have a set-aside designation. The University of Chicago has previously received prime and sub awards from federal agencies like...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price definitive contract to Rush University Medical Center, a non-profit academic medical center and hospital located in Chicago, Illinois, to conduct a study on Candida auris. The contract has a potential value of $387,250.00 and a completion date of September 29, 2019. The contract does not have a set-aside designation. Based on Rush University Medical Center's history of federal contracting and grant work, this study is likely part of the agency's efforts to research and address infectious disease threats.

Generated 3/21/24, 8:17 PM